Northwest Biotherapeutics, Inc.
NWBO
$0.23
$0.00-0.78%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 55.15% | 49.81% | 12.15% | 2.30% | -51.80% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.28% | -12.22% | -22.79% | -5.60% | 29.11% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 38.64% | 23.69% | -5.30% | -1.53% | -38.57% |
|
|
|||||
| Total Current Assets | 38.64% | 23.69% | -5.30% | -1.53% | -38.57% |
| Net Property, Plant & Equipment | -3.21% | 0.69% | -3.77% | -5.02% | 5.16% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.28% | -0.54% | 1.10% | 1.11% | 4.76% |
| Total Assets | 4.39% | 4.68% | -3.72% | -4.08% | -6.89% |
|
|
|||||
| Total Accounts Payable | 50.03% | 56.24% | 37.51% | 65.65% | 45.27% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 79.09% | 83.68% | 62.00% | 259.69% | -7.58% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 26.86% | 18.43% | 10.85% | 21.78% | 52.53% |
| Total Finance Division Other Current Liabilities | 60.43% | 75.73% | 38.97% | 17.17% | -13.75% |
| Total Other Current Liabilities | 60.43% | 75.73% | 38.97% | 17.17% | -13.75% |
| Total Current Liabilities | 47.58% | 49.39% | 33.02% | 51.04% | 21.01% |
|
|
|||||
| Total Current Liabilities | 47.58% | 49.39% | 33.02% | 51.04% | 21.01% |
| Long-Term Debt | 29.98% | 12.25% | 96.90% | 39.31% | 121.68% |
| Short-term Debt | 79.09% | 83.68% | 62.00% | 259.69% | -7.58% |
| Capital Leases | -7.89% | 6.03% | 1.98% | -0.36% | 16.79% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -63.83% | -6.00% | -6.00% | -5.05% | 3.30% |
| Total Liabilities | 34.52% | 35.15% | 36.94% | 41.09% | 35.70% |
|
|
|||||
| Common Stock & APIC | 4.68% | 4.74% | 4.56% | 4.14% | 4.93% |
| Retained Earnings | -6.34% | -5.90% | -6.15% | -6.16% | -5.55% |
| Treasury Stock & Other | -1,100.00% | -189.88% | -36.26% | 103.43% | -103.36% |
| Total Common Equity | -35.61% | -31.23% | -35.75% | -43.66% | -23.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -15.60% | -26.66% | -26.09% | -17.15% | -42.61% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -15.60% | -26.66% | -26.09% | -17.15% | -42.61% |
|
|
|||||
| Total Common Equity | -35.61% | -31.23% | -35.75% | -43.66% | -23.03% |
| Total Preferred Equity | -15.60% | -26.66% | -26.09% | -17.15% | -42.61% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -48.27% | -50.03% | -58.66% | -67.85% | -71.52% |
|
|
|||||